BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 268183)

  • 1. Comparative study of Amikacin (BB-K8) and gentamicin activity in vitro against Proteus rettgeri.
    Pérez-Rodríguez F; Bermúdez RH; de Brau CJ
    Bol Asoc Med P R; 1977 Jul; 69(7):222-6. PubMed ID: 268183
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invitro comparative evaluation of aminoglycosides at a cancer centre.
    Biswas SK; Kelkar RS
    Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses.
    Orsini JA; Benson CE; Spencer PA; Van Miller E
    Am J Vet Res; 1989 Jun; 50(6):923-5. PubMed ID: 2669575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiologic consequences of amikacin use during a 42-month period.
    Berk SL; Alvarez S; Ortega G; Verghese A; Holtsclaw-Berk SA
    Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of gram negative bacteria to amikacin and its comparison with three other aminoglycoside antibiotics.
    Daniel J; Thomas M; Shanmugam J
    Indian J Pathol Microbiol; 1985 Apr; 28(2):115-9. PubMed ID: 3835114
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possible errors in the interpretation of bacterial sensitivity to aminoglycoside antibiotics].
    García Hierro P; Ponte Miramontes MC; Soriano García F
    Rev Clin Esp; 1980 Oct; 159(2):87-90. PubMed ID: 7209044
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin.
    Yu PK; Washington JA
    Antimicrob Agents Chemother; 1973 Aug; 4(2):133-9. PubMed ID: 4208506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
    Kazmierczak A; Gailliard MC; Pothier P; Siebor E; Portier H
    Nouv Presse Med; 1979 Oct; 8(42):3399-402. PubMed ID: 537884
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid development of resistance of gentamicin, tobramycin and amikacin by E. coli 07.
    Humble MW; Bettelheim KA
    N Z Med J; 1978 May; 87(612):366. PubMed ID: 353599
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB; Penner JL
    Can Med Assoc J; 1975 Jul; 113(1):29-31. PubMed ID: 807310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of five aminoglycosides for treatment.
    Rosin H; Naumann P; Reintjens E; Köhler M
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
    Knothe H; Krcméry V; Mitsuhashi S
    Zentralbl Bakteriol A; 1980 Mar; 246(3):373-8. PubMed ID: 6775445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro amikacin sensitivity testing.
    Vaidya AK; Salvekar PM; Wagle NM; Merchant SM
    Indian Pediatr; 1986 Jun; 23(6):415-8. PubMed ID: 3744520
    [No Abstract]   [Full Text] [Related]  

  • 16. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa.
    Ximenes J; Bassoi ON; de Menezes JP; Fry W
    J Int Med Res; 1976; 4(3):165-75. PubMed ID: 829072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity of amikacin and gentamicin.
    Shah RM; Heetderks G; Stille W
    Chemotherapy; 1977; 23(4):260-6. PubMed ID: 405182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activity in vitro of the new cephalosporin antibiotic HR 810 with gentamicin and amikacin against multiresistant pathogens.
    Seibert G; Limbert M; Klesel N
    J Antibiot (Tokyo); 1984 Aug; 37(8):929-30. PubMed ID: 6480508
    [No Abstract]   [Full Text] [Related]  

  • 20. Amikacin: in vitro bacteriological studies, levels in human serum, lung and heart tissue, and clinical results.
    Faragó E; Kiss J; Gömöry A; Aranyosi J; Juhász I; Mihóczy L
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):421-8. PubMed ID: 511416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.